Stay updated on VenDex vs PomDex in t(11;14)+ MM Clinical Trial
Sign up to get notified when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.

Latest updates to the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now indicates recruitment is closed and adds sections to help readers read the study record, join the study, and understand the interventions. It also standardizes the Intervention/Treatment label and includes a revision note (v3.6.0), while removing older terms such as 'Intervention / Treatment' and 'Multiple myeloma' from the page.SummaryDifference0.2%

- Check19 days agoChange DetectedGeographic location details for the study sites were updated to include Kharkiv Oblast and a specific Kharkiv, Kharkiv Oblast, Ukraine address. Related topics such as Multiple myeloma and MedlinePlus Genetics were added, and an older Kharkivs’ka Oblast’ variant with the previous address and an older revision tag were removed.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page footer now displays Revision: v3.5.4. Older footer elements and sponsor-related labels (Related info, AbbVie, Helpful Links Provided by, and Revision: v3.5.3) were removed, indicating a cleanup of the footer area.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision tag was updated from v3.5.2 to v3.5.3, indicating a minor patch to the page's documentation. This change does not affect study details or user-facing content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded links to related topics for Multiple myeloma and MedlinePlus Genetics on the page. These educational resources do not change study content or operations.SummaryDifference0.1%

Stay in the know with updates to VenDex vs PomDex in t(11;14)+ MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.